Navigation Links
Quantros Acquires MEDMARX(R) from United States Pharmacopeia (USP)
Date:12/8/2008

SAN FRANCISCO, Dec. 8 /PRNewswire/ -- U.S. Pharmacopeia (USP) Convention, an official public standards-setting authority for all prescription and over-the-counter medicines sold in the United States, on December 4, 2008 transferred all rights, ownership and management of the overall MEDMARX reporting program to Quantros. This announcement comes one year after Quantros and USP formalized a strategic partnership wherein Quantros assumed all operations, support, marketing and sales for the MEDMARX program. During the past year Quantros has accelerated enhancements to the MEDMARX platform including seamless integration with the Quantros Safety and Risk Management (SRM) solution for patient safety to provide greater visibility and analysis capabilities related to Medication Errors and Adverse Drug Reactions (ADRs). Quantros and USP have worked collaboratively over the past year to create a more robust database of medication errors and provide broader access to the MEDMARX program. These efforts have led to an expanded comparative medication error events data repository for the advancement of medication safety improvement efforts within healthcare. According to USP, "Quantros is well positioned to take over the complete MEDMARX operation, from data collection to analysis to dissemination."

Under the terms of this transition, Quantros will take full ownership of the MEDMARX program and all associated intellectual property. Quantros will continue to further and manage all aspects of the MEDMARX program including operations, support, application enhancement and sales and marketing as it has done for the past year. In addition, Quantros will work with the MEDMARX program to support public health knowledge concerning medication errors and ADRs. The MEDMARX program will continue to be offered as a standalone application or as an integrated offering with Quantros SRM. Quantros will continue to collaborate with USP to assist in their ongoing data standards initiatives based on the knowledge created from the MEDMARX program.

Quantros continues to expand its presence in the patient safety arena. With the advent of Patient Safety Organizations (PSO), heightened consumer awareness and sensitivity towards medical errors, and new reimbursement rules surrounding preventable medical errors, the need for actionable, intelligent knowledge is at a premium. With the Quantros data repository expanding across safety, quality, compliance and financial performance data, there is a pressing need for aggregated views for making informed decisions on which interventions and actions will have the greatest benefit to a healthcare organization. The MEDMARX data repository is a key component of this expanded presence and knowledge base.

"We appreciate USP entrusting Quantros with the MEDMARX program and for ensuring its continued value is available to the healthcare industry," said Dr. Sanjaya Kumar, Quantros President and Chief Medical Officer. "Together, the two organizations have focused their combined efforts on delivering high value medication related clinical informatics solutions, assisting healthcare providers in capturing key data and evaluating medication errors and ADRs. This has enabled healthcare professionals to determine the impact of medication errors, thereby improving their care delivery systems and processes."

According to Roger L. Williams, Executive Vice President and CEO, USP, "The MEDMARX program has reached the level of development where there is greater benefit to public health for USP to transfer core activities of this program to Quantros, our strategic partner, who will bring the program to the next level of effectiveness and impact."

Today the MEDMARX program provides subscription-based users with access to the world's largest anonymous and de-identified medication error and ADR records repository. The MEDMARX database contains more than 1.5 million records and is increasing at a rate of more than one percent month over month. To find out more about gaining access to and utilizing the MEDMARX program, email info@quantros.com or call 1-877-QUANTROS (782-6876).

About Quantros

Quantros provides real-time solutions for safety and risk management, outcomes and performance monitoring, accreditation and compliance, and surveillance and decision support for leading healthcare providers throughout the nation. Quantros' web delivered applications provide a standard platform that creates actionable knowledge that helps its clients save lives, improve quality, and conserve assets. Through a variety of direct sales and vendor partners, more than 2,000 healthcare facilities use Quantros' web-based technology solutions every day.

Quantros team members include physicians, nurses and healthcare professionals as well as an experienced team of information technology specialists. Visit Quantros on the web at http://www.quantros.com.

The Institute for Safe Medication Practices (ISMP)

The Institute for Safe Medication Practices is a nonprofit organization recognized worldwide as the premier education resource for understanding and preventing medication errors. ISMP represents more than 30 years of experience in helping keep patients safe, and continues to lead efforts to improve the medication use process. Working with health care practitioners and institutions, regulatory and accrediting agencies, consumers, professional organizations, the pharmaceutical industry, and others, ISMP also provides timely, accurate medication safety information to the healthcare community, policy makers, and the general public. For more information on ISMP, or to read more about the 2004 ISMP Medication Safety Self Assessment for Hospitals, visit the Institute's web site at http://www.ismp.org.


'/>"/>
SOURCE Quantros
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. t2cure Acquires Patent Family on In Vitro Potency Testing of Stem Cells for Cardiovascular Application
2. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
3. Vyta Corp Acquires 100% Ownership of BIOAGRA, LLC
4. Affitech Acquires Pharmexas Diabody Technology
5. Millstone Medical Outsourcing Acquires New Facility to Accommodate Growing Business, Provide Additional Clean Room Capacity
6. CPA Acquires Renowned German Patent Research Specialist, SVPG
7. Circassia Acquires North American and Japanese Rights to Dopexamine
8. Advanced Instruments Acquires D & F Control Systems Inc.
9. Milestone Scientific Acquires Additional Patent Rights for Painless Injections and Resolves Related Litigations
10. MediCult Acquires US-Based MidAtlantic Diagnostics to Further Strengthen ART Presence
11. Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Global Stem Cells ... with Singapore-based Global Stem Cells Network (GSCN) and its affiliate Global Medical ... the latest adipose and bone marrow therapies. , Through the new collaboration, ...
(Date:2/9/2016)... ... February 08, 2016 , ... Date ... S. Blumberg Institute at the Pennsylvania Biotechnology Center of Bucks County, 3805 Old ... Commonwealth Medical College (TCMC) will hold an open house for participants to learn ...
(Date:2/9/2016)... Angeles, CA (PRWEB) , ... February 09, 2016 ... ... and strategic changes over the years and Open Access publishing is one of ... , With its 700+ open access journals and 3000+ International ...
(Date:2/9/2016)... , February 9, 2016 Three-Year Initiative ... Children to Take Part in Life-Changing Camp ... initiative designed to positively affect the lives of children born with ... --> SHPG ) is announcing a new initiative designed ... as well as the future of rare disease care. --> ...
Breaking Biology Technology:
(Date:2/2/2016)... Calif. , Feb. 2, 2016  Based ... market, Frost & Sullivan recognizes US-based Intelligent Retinal ... Frost & Sullivan Award for New Product Innovation. ... in North America , is ... the rapidly growing diabetic retinopathy market. The IRIS ...
(Date:1/27/2016)... , Jan. 27, 2016  Rite Track, Inc. a ... West Chester, Ohio announced today ... service staff, based in Austin, Texas ... ability to provide modifications, installations and technical support offerings ... CEO of PLUS, commented, "PLUS has provided world class ...
(Date:1/21/2016)... --> ... report "Emotion Detection and Recognition Market by Technology (Bio-Sensors, NLP, ... Voice Recognition and Others), Services, Application Areas, End ... published by MarketsandMarkets, the global Emotion Detection and ... Billion by 2020, at a CAGR of 31.9%, ...
Breaking Biology News(10 mins):